Production of virus-receptive pluripotent stem cell (PSC)-derived hepatocytes
US10093903B2 · kind B2 · utility
2Cited by
1References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 19, 2016 |
| Grant date | Oct 9, 2018 |
| Priority date | — |
| Expiry date | Oct 19, 2036 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/02
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present disclosure provides methods for maturing hepatocytes comprising culturing with cyclic adenosine monophosphate and a Janus kinase inhibitor. There is also provided a method for screening inhibitors of hepatitis B virus infection and/or replication.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.